{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:00:58Z","timestamp":1780498858030,"version":"3.54.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["ug1ey014231"],"award-info":[{"award-number":["ug1ey014231"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To evaluate the effect of diabetic retinopathy (DR) lesion type (hemorrhages and\/or microaneurysms, intraretinal microvascular abnormalities, new vessels elsewhere, and venous beading), severity, and distribution on disease worsening based on the Early Treatment Diabetic Retinopathy Study Diabetic Retinopathy Severity Scale.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Post hoc analysis of a multicenter observational study of 544 eyes with nonproliferative DR and an Early Treatment Diabetic Retinopathy Study Diabetic Retinopathy Severity Scale score of Level 35 to 53. Disease worsening was defined as Early Treatment Diabetic Retinopathy Study Diabetic Retinopathy Severity Scale worsening by \u22652 steps from baseline or receipt of DR treatment over 4 years. DR lesions were evaluated based on the entire visible area in the ultrawide field color (UWF-color) and UWF-fluorescein angiography images.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A significantly greater risk of disease worsening was associated with the presence of more severe lesion grades outside the Early Treatment Diabetic Retinopathy Study fields for hemorrhages and\/or microaneurysms (hazard ratio: 1.74 [95% confidence interval, 1.28\u20132.36]) on UWF-color and for hemorrhages and\/or microaneurysms (1.90 [1.38\u20132.61]), intraretinal microvascular abnormalities (1.68 [1.13\u20132.49]), and new vessels elsewhere (1.99 [1.36\u20132.93]) on UWF-fluorescein angiography.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>These results suggest that features on UWF-color and UWF-fluorescein angiography may provide additional prognostic value in determining the risk of disease worsening. The use of UWF-fluorescein angiography improves identification of DR lesions and disease progression. However, the optimal method of disease risk assessment on UWF imaging still needs to be determined.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004263","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T16:06:20Z","timestamp":1726502780000},"page":"44-51","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["DIABETIC RETINOPATHY LESION TYPES AND DISTRIBUTION ON ULTRAWIDE FIELD IMAGING AND THE RISK OF DISEASE WORSENING OVER TIME"],"prefix":"10.1097","volume":"45","author":[{"given":"Paolo S.","family":"Silva","sequence":"first","affiliation":[{"name":"Harvard Department of Ophthalmology, Joslin Diabetes Center, Beetham Eye Institute, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Liu","sequence":"additional","affiliation":[{"name":"Jaeb Center for Health Research, Tampa, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd P.","family":"Aiello","sequence":"additional","affiliation":[{"name":"Harvard Department of Ophthalmology, Joslin Diabetes Center, Beetham Eye Institute, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Melia","sequence":"additional","affiliation":[{"name":"Jaeb Center for Health Research, Tampa, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Sun","sequence":"additional","affiliation":[{"name":"Harvard Department of Ophthalmology, Joslin Diabetes Center, Beetham Eye Institute, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the DRCR Retina Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250807","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0161-6420(13)38012-9","article-title":"Grading diabetic retinopathy from stereoscopic color fundus photographs\u2014an extension of the modified Airlie House classification. ETDRS report number 10","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"key":"R2-20250807","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0161-6420(13)38014-2","article-title":"Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"key":"R3-20250807","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/jamaophthalmol.2022.3131","article-title":"Association of predominantly peripheral lesions on ultra-widefield imaging and the risk of diabetic retinopathy worsening over time","volume":"140","author":"Marcus","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"R4-20250807","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamaophthalmol.2018.4982","article-title":"Comparison of early treatment diabetic retinopathy study standard 7-field imaging with ultrawide-field imaging for determining severity of diabetic retinopathy","volume":"137","author":"Aiello","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"R5-20250807","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.ophtha.2013.05.004","article-title":"Peripheral lesions identified by mydriatic ultrawide field imaging: distribution and potential impact on diabetic retinopathy severity","volume":"120","author":"Silva","year":"2013","journal-title":"Ophthalmology"},{"key":"R6-20250807","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ajo.2020.05.021","article-title":"Quantitative assessment of the severity of diabetic retinopathy","volume":"218","author":"Sadda","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"R7-20250807","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.2337\/dc12-0346","article-title":"Assessment of diabetic retinopathy using nonmydriatic ultra-widefield scanning laser ophthalmoscopy (Optomap) compared with ETDRS 7-field stereo photography","volume":"35","author":"Kernt","year":"2012","journal-title":"Diabetes Care"},{"key":"R8-20250807","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jdiacomp.2014.08.009","article-title":"Comparison between Early Treatment Diabetic Retinopathy Study 7-field retinal photos and non-mydriatic, mydriatic and mydriatic steered widefield scanning laser ophthalmoscopy for assessment of diabetic retinopathy","volume":"29","author":"Rasmussen","year":"2015","journal-title":"J Diabetes Complications"},{"key":"R10-20250807","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jamaophthalmol.2022.3130","article-title":"Association of ultra-widefield fluorescein angiography\u2013identified retinal nonperfusion and the risk of diabetic retinopathy worsening over time","volume":"140","author":"Silva","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"R11-20250807","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/08820538.2020.1729818","article-title":"Diabetic retinopathy and ultrawide field imaging","volume":"35","author":"Ashraf","year":"2020","journal-title":"Semin Ophthalmol"},{"key":"R12-20250807","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0161-6420(81)34983-5","article-title":"Midperipheral fundus involvement in diabetic retinopathy","volume":"88","author":"Shimizu","year":"1981","journal-title":"Ophthalmology"},{"key":"R13-20250807","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0161-6420(84)34126-4","article-title":"Distribution of capillary nonperfusion in early-stage diabetic retinopathy","volume":"91","author":"Niki","year":"1984","journal-title":"Ophthalmology"},{"key":"R14-20250807","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1097\/IAE.0000000000003479","article-title":"Assessment of fluorescein angiography nonperfusion in eyes with diabetic retinopathy using ultrawide field retinal imaging","volume":"42","author":"Silva","year":"2022","journal-title":"Retina"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:01:05Z","timestamp":1754524865000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004263","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}